Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Alzheimers Dis. 2019;68(4):1625–1633. doi: 10.3233/JAD-181242

Table 1.

Demographics and baseline testing

PIB Negative
PIB Positive
p Total
N/Mean %/SD N/Mean %/SD N/Mean %/SD
Age, y 71.9 3.1 74.5 4.3 0.139 73.2 3.9
Women, N 5 50.0% 2 20.0% 0.160 7 35.0%
APOE ɛ4, N 3 30.0% 4 40.0% 0.639 7 35.0%
Education, y 16.6 1.7 16.0 2.8 0.565 16.3 2.3
MCBP for PIB 0.03 0.03 0.46 0.26 <0.001 0.25 0.28
CSF Aβ42, pg/mL 840.4 221.8 524.5 206.6 0.004 682.5 264.2
tau, pg/mL 227.9 64.3 523.5 285.1 0.001 375.7 251.9
ptau181, pg/mL 45.2 8.5 85.7 36.4 0.007 65.5 33.1
Selective Reminding Test - Free Recall 34.6 5.1 28.1 7.2 0.031 31.4 6.9
Animal Naming 23.0 5.8 19.6 4.6 0.166 21.3 5.4
Trailmaking A, s 27.7 7.4 32.7 10.7 0.240 30.2 9.3
Trailmaking B, s 79.4 39.8 92.1 41.1 0.516 85.8 39.8
Santa Barbara Sense of Direction 5.8 1.0 4.7 1.2 0.052 5.2 1.2
Near acuity 68.0 1.8 65.5 3.9 0.083 66.8 3.2
Far acuity 48.6 7.3 48.4 43.6 0.950 48.5 6.8
Contrast sensitivity 21.8 8.5 21.0 8.4 0.834 21.4 8.2

PIB, Pittsburgh Compound B; SD, standard deviation; MCBP, mean cortical binding potential; s, seconds.